Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 40 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/1/1998


1.		Phase II/III Randomized Study of Fluorouracil/Leucovorin with vs without Oxaliplatin for Inoperable Metastatic Colorectal Cancer (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 to 75								FRE-DEB95-OXA-01 EU-96023

Last Modified: 5/17/2007 First Published: 5/1/1998


2.		Phase III Randomized Study of Leucovorin Calcium Plus Fluorouracil With Either Irinotecan or Oxaliplatin in Patients With Recurrent Metastatic Colorectal Cancer (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Pharmaceutical / Industry				FRE-GERCOR-C97-3/CPTF308 FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260

Last Modified: 4/24/2008 First Published: 8/1/1998


3.		Phase III Randomized Study of Chronomodulated Versus Nonchronomodulated Administration of Fluorouracil, Leucovorin Calcium, and Oxaliplatin as First Line Treatment in Patients With Locoregionally Recurrent or Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18-75								EORTC-05963 NCT00003287

Last Modified: 12/11/2008 First Published: 11/1/1998


4.		Phase III Randomized Study of Combinations of Oxaliplatin, Fluorouracil, Leucovorin Calcium, and Irinotecan as Initial Therapy in Patients With Advanced Adenocarcinoma of the Colon and Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				NCCTG-N9741 CAN-NCIC-CO13, CLB-89804, E-N9741, SWOG-N9741, N9741, NCT00003594, CO13

Last Modified: 6/20/2008 First Published: 3/1/2000


5.		Phase III Study of Fluorouracil and Leucovorin Calcium With or Without Oxaliplatin in Patients With Stage II or III Carcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Any age				NCI				NSABP-C-07 NCT00004931

Last Modified: 6/18/2008 First Published: 4/1/2000


6.		Phase III Randomized Study of Irinotecan Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Colorectal Cancer Previously Treated With Fluorouracil

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NCCTG-N9841 ECOG-N9841, SWOG-N9841, NCT00005036, N9841

Last Modified: 7/2/2003 First Published: 11/1/2000


7.		Phase III Randomized Study of Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 80				Other				FRE-GERCOR-OPTIMOX-2000 EU-20034, NCT00006468

Last Modified: 3/25/2008 First Published: 11/1/2000


8.		Phase III Study of Surgery With or Without Neoadjuvant and Adjuvant Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Resectable Colorectal Liver Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 80				Other				EORTC-40983 AGITG-EORTC-40983, ALM-CAO-EORTC-40983, CRUK-LON-EORTC-40983, FFCD-EORTC-40983, EU-20048, CRC-EORTC-40983, NCT00006479

Last Modified: 7/17/2007 First Published: 1/1/2001


9.		Phase III Randomized Study of Fluorouracil With Leucovorin Calcium and Either Irinotecan or Oxaliplatin in Patients With Unresectable Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				MRC-CR08-FOCUS EU-20038, ISRCTN79877428, NCT00008060

Last Modified: 4/1/2002 First Published: 1/1/2001


10.		Phase III Randomized Study of Fluorouracil and Leucovorin Calcium Versus Oxaliplatin Alone Versus Fluorouracil, Leucovorin Calcium, and Oxaliplatin in Patients With Metastatic Colorectal Carcinoma (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				SANOFI-EFC4584 BRCC-00036, NCT00008281

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute